<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="22824">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02809664</url>
  </required_header>
  <id_info>
    <org_study_id>6287</org_study_id>
    <nct_id>NCT02809664</nct_id>
  </id_info>
  <brief_title>Feasibility and Safety of Ultrasound Guided Installation Central Subclavian Catheter Through Supraclavicular Way</brief_title>
  <official_title>Feasibility and Safety of Ultrasound Guided Installation Central Subclavian Catheter Through Supraclavicular Way</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our goal is to demonstrate the feasibility of laying uncomplicated ultrasound-guided central
      subclavian catheter by supraclavicular route in the newborn.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">January 2017</completion_date>
  <primary_completion_date type="Anticipated">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>success rate without complications laying catheter ultrasound guided subclavian by supraclavicular route in newborn</measure>
    <time_frame>1h after intervention</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Heart Diseases</condition>
  <condition>Diseases, Metabolic</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients hospitalized in the neonatal intensive care or neonatal intensive care.

        The 3 types of taken most often encountered load are:

          1. support for prematurity at birth or poor adaptation at birth requiring intensive care
             or ventilatory support.

          2. management of congenital heart diseases including ducto-dependent, awaiting surgery.

          3. care for severe medical condition exposing one or more organ failure, between 0 and
             28 days of life (severe infections, metabolic diseases, severe dehydration ...)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient hospitalized in the neonatal intensive care or neonatal intensive care at the
             University Hospital of Hautepierre

          -  All infants less than 44 weeks corrected age who require a surgical approach

          -  In the first line if neonate over 34 weeks corrected age requiring dual carriageway
             catheter

          -  After Failure or inability laying KTEC for children between 30 and 34 weeks of age
             corrected and heavy over 1000

        Exclusion Criteria:

          -  Nouveau-né de poids &lt; 1000g

          -  Nouveau-né de moins de 30 semaines d'âge corrigé

          -  Choix d'une autre voie d'abord plus judicieux (KTVO, KTC broviac)

          -  Sortie avant retrait du KTC
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>43 Weeks</minimum_age>
    <maximum_age>44 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre Kuhn, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Strasbourg, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pierre Kuhn, MD</last_name>
    <phone>33 3 88 12 77 86</phone>
    <email>Pierre.kuhn@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Olfa KOOBAR, MD</last_name>
    <phone>33 3 88 12 77 57</phone>
    <email>olfa.koobar@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service de réanimation néonatale - HOPITAL DE HAUTEPIERRE</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre KUHN, MD, PhD</last_name>
      <phone>33 3 88 12 77 79</phone>
      <email>Pierre.Kuhn@chru-strasbourg.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <lastchanged_date>January 5, 2017</lastchanged_date>
  <firstreceived_date>January 4, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Metabolic Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
